![]() |
Volumn 210, Issue 4, 2010, Pages 428-435
|
Recurrence after Esophagectomy for Adenocarcinoma: Defining Optimal Follow-Up Intervals and Testing
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARCINOEMBRYONIC ANTIGEN;
ADJUVANT THERAPY;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
BONE PAIN;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL FEATURE;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED STUDY;
DIAGNOSTIC IMAGING;
DYSPHAGIA;
ESOPHAGEAL ADENOCARCINOMA;
ESOPHAGUS RESECTION;
FEMALE;
FOLLOW UP;
HUMAN;
INTESTINE OBSTRUCTION;
LABORATORY TEST;
LOWER ESOPHAGUS SPHINCTER;
LYMPH NODE METASTASIS;
MAJOR CLINICAL STUDY;
MALE;
NEUROLOGIC DISEASE;
PHYSICAL EXAMINATION;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
WEIGHT REDUCTION;
ADENOCARCINOMA;
ADULT;
AGED;
AGED, 80 AND OVER;
CALIFORNIA;
CHEMOTHERAPY, ADJUVANT;
ESOPHAGEAL NEOPLASMS;
ESOPHAGECTOMY;
ESOPHAGOGASTRIC JUNCTION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
KAPLAN-MEIERS ESTIMATE;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NEOADJUVANT THERAPY;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
RADIOTHERAPY, ADJUVANT;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
|
EID: 77949892830
PISSN: 10727515
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jamcollsurg.2010.01.006 Document Type: Article |
Times cited : (156)
|
References (5)
|